Insider Transactions in Q4 2024 at Gilead Sciences, Inc. (GILD)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 16
2024
|
Andrew D Dickinson Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
8,500
-6.03%
|
$773,500
$91.96 P/Share
|
|
Dec 13
2024
|
Sandra Patterson SVP, Controllership |
SELL
Payment of exercise price or tax liability
|
Direct |
157
-0.42%
|
$14,287
$91.86 P/Share
|
|
Dec 13
2024
|
Sandra Patterson SVP, Controllership |
BUY
Exercise of conversion of derivative security
|
Direct |
157
+0.42%
|
-
|
|
Dec 10
2024
|
Deborah H Telman EVP, Corporate Affairs & GC |
SELL
Payment of exercise price or tax liability
|
Direct |
306
-1.42%
|
$28,152
$92.34 P/Share
|
|
Dec 10
2024
|
Deborah H Telman EVP, Corporate Affairs & GC |
BUY
Exercise of conversion of derivative security
|
Direct |
639
+2.87%
|
-
|
|
Dec 10
2024
|
Sandra Patterson SVP, Controllership |
SELL
Payment of exercise price or tax liability
|
Direct |
408
-1.09%
|
$37,536
$92.34 P/Share
|
|
Dec 10
2024
|
Sandra Patterson SVP, Controllership |
BUY
Exercise of conversion of derivative security
|
Direct |
901
+2.35%
|
-
|
|
Dec 10
2024
|
Merdad Parsey Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,771
-2.09%
|
$162,932
$92.34 P/Share
|
|
Dec 10
2024
|
Merdad Parsey Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,820
+4.32%
|
-
|
|
Dec 10
2024
|
Daniel Patrick O'Day Chairman & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,762
-0.94%
|
$438,104
$92.34 P/Share
|
|
Dec 10
2024
|
Daniel Patrick O'Day Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,295
+1.99%
|
-
|
|
Dec 10
2024
|
Andrew D Dickinson Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,686
-1.18%
|
$155,112
$92.34 P/Share
|
|
Dec 10
2024
|
Andrew D Dickinson Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,640
+2.49%
|
-
|
|
Dec 10
2024
|
Johanna Mercier Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,739
-2.26%
|
$159,988
$92.34 P/Share
|
|
Dec 10
2024
|
Johanna Mercier Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,752
+4.65%
|
-
|
|
Nov 29
2024
|
Andrew D Dickinson Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
248,645
-39.54%
|
$22,875,340
$92.76 P/Share
|
|
Nov 29
2024
|
Andrew D Dickinson Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
248,645
+13.47%
|
$17,156,505
$69.62 P/Share
|
|
Nov 27
2024
|
Merdad Parsey Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
164,211
-18.07%
|
$14,943,201
$91.88 P/Share
|
|
Nov 27
2024
|
Merdad Parsey Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
145,413
+26.6%
|
$8,870,193
$61.65 P/Share
|
|
Nov 26
2024
|
Jeffrey Bluestone Director |
SELL
Open market or private sale
|
Direct |
6,788
-43.21%
|
$617,708
$91.39 P/Share
|
|
Nov 26
2024
|
Jeffrey Bluestone Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+27.22%
|
$610,000
$61.26 P/Share
|
|
Nov 06
2024
|
Johanna Mercier Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
5,000
-6.4%
|
$455,000
$91.28 P/Share
|
|
Nov 06
2024
|
Merdad Parsey Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
25,590
-10.61%
|
$2,328,690
$91.5 P/Share
|
|
Nov 06
2024
|
Merdad Parsey Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+16.65%
|
$1,425,000
$57.92 P/Share
|
|
Oct 25
2024
|
Deborah H Telman EVP, Corporate Affairs & GC |
SELL
Payment of exercise price or tax liability
|
Direct |
242
-1.14%
|
$21,538
$89.0 P/Share
|
|
Oct 25
2024
|
Deborah H Telman EVP, Corporate Affairs & GC |
BUY
Exercise of conversion of derivative security
|
Direct |
514
+2.36%
|
-
|
|
Oct 01
2024
|
Merdad Parsey Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,000
-1.96%
|
$166,000
$83.83 P/Share
|